how many people take semaglutide GLP-1 Injections for Medical Weight Loss Ozempic Statistics: GLP-1 Weight Loss

Importantly, the decision applies only to the obesity indicationtirzepatide remains available in its anti-diabetic medication (ADM) formulation (sold as Mounjaro) for patients with type 2 diabetes

With the use of these medications for weight loss being so new, no solid recommendations for nutrition care during treatment currently exist, says Tewksbury

Well also discuss where to find the best Vitamin C and glutathione serum from Isomers Skincare

Part of Special Issue: The Therapeutic Potential of Novel and Emerging Anti-fibrotic Drugs The Anti-Fibrotic Potential of GLP-1 and GIP Receptor Agonists in Chronic Inflammatory Disorders: Mechanisms and Therapeutic Horizons Simon W

Managing the side effects of semaglutide involves several strategies, such as: Starting treatment with a smaller dose and gradually raising it can help your body adjust to the medication

Certain features warrant prompt medical evaluation: Severe muscle pain or weakness , particularly if accompanied by dark urine, which may indicate rhabdomyolysis (a rare but serious condition involving muscle breakdown) Joint swelling, redness, or warmth , which could suggest inflammatory arthritis or infection (septic arthritis) Pain that significantly impairs daily activities or does not respond to simple analgesia Systemic symptoms such as fever, unexplained weight loss (beyond expected therapeutic effect), or night sweats New or worsening pain following dose escalation, which may require dose adjustment or further investigation Sudden, severe pain in the right upper abdomen , possibly with fever or jaundice, which could indicate gallbladder disease (a recognised risk with GLP-1 receptor agonists) [1] [5] Patients should also seek advice if they experience other concerning adverse effects of Ozempic, including: Persistent nausea or vomiting leading to dehydration or reduced fluid intake Symptoms of hypoglycaemia (tremor, sweating, confusion), particularly if taking Ozempic with insulin or sulphonylureas Severe abdominal pain, which may indicate pancreatitis (a known but uncommon risk with GLP-1 receptor agonists) [1] [5] Visual changes or signs of diabetic retinopathy progression For urgent concerns outside of GP hours, patients should contact NHS 111